UncategorizedCould OpenAI’s latest model drive progress in longevity science? Empower Meds / November 25, 2025
UncategorizedBritish researchers land £69m to advance treatments for neurodegenerative diseases Empower Meds / November 25, 2025
UncategorizedWeight loss drugs study reveals healthspan benefits and risks Empower Meds / November 25, 2025
UncategorizedArctic lands a cool €26.5m to advance oral dementia drug Empower Meds / November 25, 2025
UncategorizedCoinbase invests in Próspera to expand global economic freedom Empower Meds / November 25, 2025
UncategorizedChatGPT4b boosts Retro Biosciences age‑reversal protein efficiency – Longevity.Technology Empower Meds / November 25, 2025
UncategorizedCombating chronic inflammation through immune diagnostics Empower Meds / November 25, 2025
UncategorizedNeko Health lands $260m for international expansion of preventive health scans Empower Meds / November 25, 2025
UncategorizedLinkGevity gears up for clinical trial of aging-focused ‘anti-necrotic’ drug Empower Meds / November 25, 2025
UncategorizedResearchers achieve bioprinting milestone with functional human heart tissue Empower Meds / November 25, 2025
